Bridge Creek Capital Management buys $4,476,210 stake in Colgate-Palmolive Company (CL)

Colgate-Palmolive Company (CL) : Bridge Creek Capital Management scooped up 840 additional shares in Colgate-Palmolive Company during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 15, 2016. The investment management firm now holds a total of 62,824 shares of Colgate-Palmolive Company which is valued at $4,476,210.Colgate-Palmolive Company makes up approximately 2.58% of Bridge Creek Capital Management’s portfolio.

Colgate-Palmolive Company closed down -1.33 points or -1.89% at $68.98 with 41,27,637 shares getting traded on Wednesday. Post opening the session at $70.2, the shares hit an intraday low of $68.81 and an intraday high of $70.32 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.

Other Hedge Funds, Including , Deroy Devereaux Private Investment Counsel Inc added CL to its portfolio by purchasing 3,000 company shares during the most recent quarter which is valued at $213,750. Colgate-Palmolive Company makes up approx 0.03% of Deroy Devereaux Private Investment Counsel Inc’s portfolio.Tufton Capital Management reduced its stake in CL by selling 216 shares or 0.24% in the most recent quarter. The Hedge Fund company now holds 88,621 shares of CL which is valued at $6,314,246. Colgate-Palmolive Company makes up approx 1.56% of Tufton Capital Management’s portfolio.Kanaly Trust Co reduced its stake in CL by selling 213 shares or 4.64% in the most recent quarter. The Hedge Fund company now holds 4,379 shares of CL which is valued at $312,004. Colgate-Palmolive Company makes up approx 0.06% of Kanaly Trust Co’s portfolio.New England Research Management boosted its stake in CL in the latest quarter, The investment management firm added 200 additional shares and now holds a total of 8,950 shares of Colgate-Palmolive Company which is valued at $634,913. Colgate-Palmolive Company makes up approx 0.55% of New England Research Management’s portfolio.

On the company’s financial health, Colgate-Palmolive Company reported $0.73 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Jan 29, 2016. Analyst had a consensus of $0.72. The company had revenue of $3899.00 million for the quarter, compared to analysts expectations of $3927.05 million. The company’s revenue was down -7.6 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.76 EPS.

Many Wall Street Analysts have commented on Colgate-Palmolive Company. Colgate-Palmolive Company was Downgraded by Sterne Agee CRT to ” Neutral” on Feb 26, 2016. Shares were Reiterated by UBS on Feb 1, 2016 to “Neutral” and Lowered the Price Target to $ 67 from a previous price target of $69 .

Colgate-Palmolive Company (Colgate) is a consumer products company whose products are marketed in more than 200 countries and territories throughout the world. The Company operates in two product segments: Oral Personal and Home Care and Pet Nutrition. The Oral Personal and Home Care product segment is operated through five geographic segments: North America Latin America Europe/South Pacific Asia and Africa/Eurasia. The Company’s oral care products include Colgate Total; Colgate Sensitive Pro-Relief; Colgate Max Fresh; Colgate Optic White and Colgate Luminous White toothpastes among others. The Company sells its personal care products under the Palmolive Protex and Softsoap brands. The Company through its Hill’s Pet Nutrition segment (Hill’s) manufactures pet nutrition products for dogs and cats.

Leave a Reply

Colgate-Palmolive Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Colgate-Palmolive Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.